Stock comparison
Jeena Sikho Lifecare Limited
JSLL.BO$72.19BHealthcare Market cap, Sector
United Therapeutics
UTHR$22.57BHealthcare Market cap, Sector
Overall winner
Jeena Sikho Lifecare Limited
JSLL.BO 70 UTHR
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
Fit scores by strategy
JSLL.BO7wins
0winsUTHR
84B
B71
87A
B76
92A
B76
66C
C62
75B
D46
91A
C64
95A
C64
Side-by-side metrics
| Metric | JSLL.BO | UTHR |
|---|---|---|
| Market cap | Winner: $72.19B | $22.57B |
| P/E (TTM) | 33.2x | 19.2x Winner |
| EV/EBIT | 24.1x | 15.2x Winner |
| ROIC (TTM) | Winner: 39.15% | 18.81% |
| Gross margin | Winner: 88.58% | 86.58% |
| Net margin | 27.68% | 40.61% Winner |
| Revenue CAGR 5y | Winner: 57.81% | 17.22% |
| EPS CAGR 5y | Winner: 86.67% | 29.84% |
| Debt / Equity | 0.3x | - Winner |
| Dividend yield | - | 0.0% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
JSLL.BO leads on
- Revenue CAGR 5y57.81%vs 17.22%+70%
- Market cap$72.19Bvs $22.57B+69%
- EPS CAGR 5y86.67%vs 29.84%+66%
- ROIC (TTM)39.15%vs 18.81%+52%
UTHR leads on
- Debt / Equity-vs 0.3x+100%
- P/E (TTM)19.2xvs 33.2x+42%
- EV/EBIT15.2xvs 24.1x+37%
- Net margin40.61%vs 27.68%+32%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.